News
Warwick Acoustics completes £6.2m funding round
Mercia Asset Management continues to back Warwick Acoustics
Histofy and Source BioScience advancing AI-powered pathology in the UK
Histofy and Source BioScience announce strategic partnership to advance AI-powered pathology in the UK. This collaboration aims to accelerate the deployment of AI-driven diagnostics, improving accuracy, efficiency, and scalability of histopathological workflows.
NanoSyrinx closes c. £10 million GBP financing and appoints Dr. Edwin Moses as Chairman
NanoSyrinx, a synthetic biology company developing nanosyringes as a novel platform for targeted intracellular delivery of biologic therapeutics, today announced that it has closed a c. £10 million (c. $13 million) financing round.
4D Medicine raises £3.4m for unique biomaterial platform
4D Medicine, a spin-out from the Universities of Birmingham and Warwick has raised £3.4m ($4.4m) in a Series A investment.
Double win for Cytecom at Medilink Awards
Warwick spinout Cytecom wins twice at Medilink Healthcare Business Awards
Warwick Acoustics completes £7m funding round
The spinout company whose patented loudspeaker technology is set to revolutionise in-car audio systems has raised a further £7m in a funding round led by Mercia and including NFU Mutual and private investors.